The Cleveland Clinic proclaimed on Tuesday that it will begin the first clinical study testing a shot intended to avoid triple-negative breast cancer, which presently does not react to hormone or aimed prescribed medications and could only precluded through mastectomy.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>